20
Participants
Start Date
February 9, 2023
Primary Completion Date
May 3, 2023
Study Completion Date
May 3, 2023
Acoziborole
Acoziborole 960 mg (three tablets of 320 mg) for oral route in fasted condition Period 2: single oral administration on Day 12
Midazolam
• Midazolam 5 mg syrup in fasted condition Period 1: Single oral dose of 5 mg administered on Day 8 Period 2: Single oral dose of 5 mg administered on Day 21
Dextromethorphan
• Dextromethorphan 15 mg syrup in fasted condition Period 1: Single oral dose of 15 mg administered on Day 1 Period 2: Single oral dose of 15 mg administered on Day 14
Clinical Research Center (CRC) Ampang Hospital, Kuala Lumpur
Drugs for Neglected Diseases
OTHER